Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 34
Filter
1.
J Chem Phys ; 140(12): 124701, 2014 Mar 28.
Article in English | MEDLINE | ID: mdl-24697464

ABSTRACT

The process of quasi-isothermal dehydration of thin films of pure water and aqueous sugar solutions is investigated with a dual experimental and theoretical approach. A nanoporous paper disk with a homogeneous internal structure was used as a substrate. This experimental set-up makes it possible to gather thermodynamic data under well-defined conditions, develop a numerical model, and extract needed information about the dehydration process, in particular the water activity. It is found that the temperature evolution of the pure water film is not strictly isothermal during the drying process, possibly due to the influence of water diffusion through the cellulose web of the substrate. The role of sugar is clearly detectable and its influence on the dehydration process can be identified. At the end of the drying process, trehalose molecules slow down the diffusion of water molecules through the substrate in a more pronounced way than do the glucose molecules.


Subject(s)
Cellulose/chemistry , Glucose/chemistry , Temperature , Trehalose/chemistry , Water/chemistry , Dehydration , Diffusion , Solutions , Thermodynamics
2.
Strahlenther Onkol ; 188(8): 707-11, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22618360

ABSTRACT

BACKGROUND AND PURPOSE: The goal of this work was to demonstrate the efficacy of stereotactic gamma knife radiosurgery (GKRS) for the treatment of neurocytoma by means of a case report and a comprehensive literature review. CASE REPORT: A locally recurrent atypical neurocytoma in the area of the left third ventricle thalamic wall occurring 7 years after primary microsurgical resection in a 59-year old woman was treated by GKRS. A marginal dose of 17 Gy was delivered to the surrounding 50% isodose. At the last follow-up, 82 months after radiosurgery, the tumor was locally controlled. For the literature review, computerized bibliographic searches of Pubmed were supplemented with hand searches of reference lists and abstracts of ASCO/ASTRO/ESTRO meetings. DISCUSSION: The present case confirms the results of the literature analysis. From 1997-2011, a total of 14 series were published providing results of GKRS in 86 patients (89 lesions). The marginal doses, which have been applied, ranged from 9.6-20.0 Gy. With median follow-up intervals between 6 and 185 months, local control was 97.2% and local tumor progression of neurocytoma after GKRS was restricted to only 4 cases. In accordance with our own experience, GKRS was not associated with a relevant early or late toxicity. CONCLUSION: GKRS can be assumed to be a safe and effective treatment modality of recurrent or residual neurocytoma.


Subject(s)
Brain Neoplasms/surgery , Cerebral Ventricle Neoplasms/surgery , Neoplasm Recurrence, Local/surgery , Neurocytoma/surgery , Radiosurgery , Third Ventricle/surgery , Brain Neoplasms/mortality , Cerebral Ventricle Neoplasms/mortality , Disease-Free Survival , Endoscopy , Female , Follow-Up Studies , Humans , Image Interpretation, Computer-Assisted , Imaging, Three-Dimensional , Magnetic Resonance Imaging , Microsurgery , Middle Aged , Neoplasm Recurrence, Local/mortality , Neurocytoma/mortality , Reoperation , Tomography, X-Ray Computed
3.
Z Orthop Unfall ; 149(6): 677-82, 2011 Dec.
Article in German | MEDLINE | ID: mdl-21271510

ABSTRACT

AIM: Pigmented villonodular synovitis (PVNS) is a rare proliferative disorder arising from synovial cells of the tendon sheets and joint capsules. The potential value of external beam radiation therapy in the interdisciplinary management of PVNS is demonstrated by a comprehensive literature review on the clinical use of radiotherapy and the results of national patterns of care study (PCS) which was conducted by the German Cooperative Group on Radiotherapy in Benign Diseases (GCG-BD) in 2008-2009. MATERIAL AND METHOD: A structured questionnaire was mailed to all 227 RT institutions in Germany to assess all previous treatments, the RT indication and techniques, the rate of local control, the functional outcome and the possible adverse effects related to the use of external beam radiation therapy (RT). For comparison of the clinical outcome data, a systematic literature research in several international electronic databases and a conventional library search were performed to identify publications addressing the use of RT for PVNS. RESULTS: Based on an overall response rate of 83.2%, the PCS was nationally representative. Ten percent of institutions presented clinical experience with the use of RT for PVNS; from this database a total of 41 treated sites from 14 institutions were evaluable for long-term analysis. The primary therapeutic approach was cytoreductive surgery in all cases. In cases of residual tissue or complete resection of extensive local recurrences, RT was applied in 39 cases (95.1%). An excellent or good functional outcome was noted in 34 cases (82.9%). The use of RT was not associated with early or late toxicity larger than RTOG grade II. The literature review identified 19 published studies (1940-2009) which represented a total of 140 cases or patients, respectively. After follow-up periods ranging from 1-250 months and administration of total doses in the range of 16-50 Gy the overall rate of local control was 84.5%. CONCLUSION: Both the results of the national PCS and the literature review demonstrate that RT is a very safe and effective treatment option for the prevention of disease progression or recurrence in PVNS after primary surgical interventions. The planned treatment volume should include the whole synovial space and eventually all invasive components of the disease. Currently, total doses in the range of 30-36 Gy are recommended.


Subject(s)
Radiotherapy, Conformal/statistics & numerical data , Synovitis, Pigmented Villonodular/epidemiology , Synovitis, Pigmented Villonodular/therapy , Data Collection , Germany/epidemiology , Humans , Prevalence , Radiotherapy, Adjuvant/statistics & numerical data , Treatment Outcome
5.
Rontgenpraxis ; 53(5): 208-20, 2001.
Article in German | MEDLINE | ID: mdl-11341017

ABSTRACT

Vertebral hemangiomas are the most common benign spinal tumors with an incidence range of 10-12%. Approximately 1-2% of the cases develop clinically significant symptoms causing the necessity for treatment. Based on our own results and a review of the literature we discuss the role of radiotherapy in the management of symptomatic vertebral hemangiomas. A total dose of 30.0 Gy given in five weekly fractions of 2.0 Gy has been proven as effective for the primary treatment and postsurgical irradiation for the prevention of a recurrence. In the literature review the results are summarized of 59 reports in the period of 1929-2000 for a total of 327 cases. The analysis of 55 studies reporting results in 210 cases which underwent primary radiotherapy or combinations with other methods of treatment demonstrated that in 54% occurred a complete relief of symptoms (CR), in 32% a partial relief (PR), and 11% were non-responders (NR). The analysis of 21 reports of 63 cases which were treated with radiotherapy as the sole measure of treatment demonstrated that 57% had a complete remission of symptoms (CR), 32% a partial remission (PR), and 11% did not respond to radiotherapy (NR). We conclude that radiation therapy is very effective in the management of symptomatic vertebral hemangiomas. With regard on the delayed effects of the irradiation, cases with an acute compression of the spinal cord should be treated primarily with a surgical procedure and a postsurgical irradiation is recommended to prevent a relapse of symptoms. In order to minimise acute or late toxicity and the risk of radiation-induced neoplasms the total dose should not exceed 30 Gy.


Subject(s)
Hemangioma/radiotherapy , Lumbar Vertebrae , Spinal Neoplasms/radiotherapy , Thoracic Vertebrae , Adult , Age Factors , Aged , Child , Combined Modality Therapy , Diagnosis, Differential , Female , Follow-Up Studies , Hemangioma/complications , Hemangioma/diagnosis , Hemangioma/epidemiology , Hemangioma/surgery , Humans , Laminectomy , Magnetic Resonance Imaging , Male , Middle Aged , Postoperative Care , Radiography, Thoracic , Radiotherapy Dosage , Sex Factors , Spinal Cord Compression/etiology , Spinal Neoplasms/complications , Spinal Neoplasms/diagnosis , Spinal Neoplasms/epidemiology , Spinal Neoplasms/surgery , Time Factors , Tomography, X-Ray Computed , Treatment Outcome
6.
J Bone Joint Surg Br ; 83(3): 332-4, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11341414

ABSTRACT

We present nine patients (five men and four women) who underwent surgical excision of clinically significant heterotopic ossification at the elbow. They also received perioperative radiation therapy using total doses between 600 and 1000 cGy. Five received fractionated radiotherapy, with two fractions of 500 cGy applied on the first two postoperative days, and the remaining four were irradiated with single doses of 600 and 700 cGy. After a mean period of observation of 7.7 months (6 to 13) none had radiological recurrence of heterotopic ossification and eight showed clinical improvement. Assessment of the functional outcome showed a mean improvement in the Morrey score from 33.3 to 84.5 points indicating a high therapeutic efficacy of prophylactic irradiation.


Subject(s)
Elbow Joint , Ossification, Heterotopic/prevention & control , Ossification, Heterotopic/radiotherapy , Adult , Elbow Joint/diagnostic imaging , Female , Humans , Male , Middle Aged , Ossification, Heterotopic/surgery , Postoperative Care , Radiography , Radiotherapy Dosage , Recurrence , Treatment Outcome
7.
Rontgenpraxis ; 54(3): 94-100, 2001.
Article in English | MEDLINE | ID: mdl-11799870

ABSTRACT

BACKGROUND: Radiotherapy (RT) has been proven effective in the management of Graves' orbitopathy in numerous studies. Most commonly is the use of conventional fractionated RT and the value of hypofractionated irradiation has not been investigated. MATERIALS AND METHODS: The results in 33 euthyroid cases who underwent RT with a total dose of 21.0 Gy given in three weekly fractions of 3.0 Gy are retrospectively analyzed. The duration of symptoms ranged from 1-84 months and all of the cases had treatment failure after previous administration of corticosteroids. After a mean follow-up period of 33.6 months the overall results were assessed according to the criteria by Donaldson et al. and for evaluation of the clinical outcome a classification with the main criteria being eye-lid changes, exophthalmos, myopathy and eye nerve involvement was used. RESULTS: At follow-up, the overall response to RT was 84.8% (28/33 cases). The analysis with the clinical classification demonstrated that in 19/33 (57.6%) cases occurred a decrease of eye lid changes and exophthalmos and 12/33 (36.4%) had a relief of myopathy. 2/33 cases (6.0%) developed an eye nerve compression causing the necessity of surgical decompression. 3/33 cases (9.0%) had a progression of at least of one of the single criteria of the score and therefore they were classified as non-responders. CONCLUSIONS: Hypofractionated RT has been proven effective for treatment of severe cases of Graves' orbitopathy in cases with a prolongated duration of symptoms. The comparison with literature data demonstrate that the results after hypofractionated RT are comparable to those obtained after conventional fractionated RT.


Subject(s)
Dose Fractionation, Radiation , Graves Disease/radiotherapy , Adult , Aged , Female , Graves Disease/diagnosis , Humans , Male , Middle Aged , Orbit/radiation effects , Radiotherapy Dosage , Retrospective Studies , Treatment Outcome
8.
Plant Dis ; 85(8): 921, 2001 Aug.
Article in English | MEDLINE | ID: mdl-30823069

ABSTRACT

Beech bark disease of American beech (Fagus grandifolia) is caused by the interaction of an introduced scale insect (Cryptococcus fagisuga) and the native fungus Nectria galligena, or N. coccinea var. faginata, which is thought to be introduced. Infestations of the insect precede development of the disease, and N. galligena is often found before N. coccinea var. faginata. Previously published records indicate that the beech scale extends as far west as eastern Ohio (2) and southern Ontario (Sajan, personal communication). The scale is now well established in several locations in both the Upper Peninsula (UP) and Lower Peninsula (LP) of Michigan. The scale insect has been found in beech stands throughout three counties (Oceana, Mason, and Muskegon) along the Lake Michigan shore in the LP, extending for at least 100 km from north to south, and occurring up to about 80 km inland. In the eastern UP, beech scale has been found in four counties (Alger, Chippewa, Luce, and Schoolcraft). The heaviest beech scale infestations are distributed around Ludington State Park in the west central LP and the Bass Lake Forest Campground in the eastern UP. The extent of the insect infestation suggests that it has been present in Michigan for many years, with anecdotal accounts placing the first observations of beech scale at Ludington State Park around 1990. These infection centers are distant from previously known beech scale infestations and are located in heavily used recreation areas, suggesting that the insect may have been transported by human activity. Perithecia of N. coccinea var. faginata were found in Ludington State Park in the LP at N 44° 1.951', W 86° 29.956' and perithecia of N. galligena were found at the Bass Lake site in the UP, at N 46° 27.748', W 85° 42.478'. The identity of the fungi collected from each location was confirmed by measurements of perithecium and ascospore morphology (1). Perithecia at both sites were scarce and difficult to find. Surveys planned for the summer and fall of 2001 will further delimit the occurrence and distribution of the pathogens involved in the disease in Michigan. To our knowledge, this is the first report of the beech scale and beech bark disease in Michigan, with N. galligena and N. coccinea var. faginata identified as the pathogens. References: (1) H. V. T. Cotter and R. O. Blanchard. Plant Dis. 65:332-334, 1981. (2) M. E. Mielke et al. Plant Dis. 69:905, 1985.

9.
Rontgenpraxis ; 53(2): 51-61, 2000.
Article in German | MEDLINE | ID: mdl-10994366

ABSTRACT

The use of radiotherapy in the treatment of Langerhans' cell histiocytosis was first reported in the literature in 1930 and has been proven as effective in numerous studies. We present the results of two female adults with eosinophilic granuloma of bone who underwent conventionally fractionated radiation therapy with total doses of 7 x 1.8 Gy and 7 x 2.0 Gy in four different sites. After observation periods raging from three months to six years local control of the disease was achieved in all treated locations. A review of 18 previously published studies include a total of 310 sites of eosinophilic granuloma of bone in 216 patients. It was demonstrated in 13 studies that the patients had complete relief of symptoms. An average of 94.3% had local control of the symptoms. Furthermore, in 12 studies for a total of 344 cases with involvement of other organs local control was reported in an average of 64.8% (range: 14.3-100%). Based on our own observations and on the literature review we conclude that low dose radiation therapy plays an important role in the management of localised Langerhans' cell histiocytosis. In order to minimise the risk of radiation induced neoplasms an accurate and precise radiation technique is required.


Subject(s)
Histiocytosis, Langerhans-Cell/radiotherapy , Adult , Combined Modality Therapy , Eosinophilic Granuloma/diagnosis , Eosinophilic Granuloma/radiotherapy , Eosinophilic Granuloma/surgery , Female , Follow-Up Studies , Histiocytosis, Langerhans-Cell/diagnosis , Histiocytosis, Langerhans-Cell/surgery , Humans , Magnetic Resonance Imaging , Prognosis , Radiotherapy Dosage , Recurrence , Time Factors , Tomography, X-Ray Computed
10.
Strahlenther Onkol ; 176(8): 361-7, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10987019

ABSTRACT

BACKGROUND: Evaluation of feasibility, tolerance and efficiency for a new 3D interstitial HDR brachytherapy technique combined with 3D external beam radiotherapy and androgen deprivation for prostate cancer. PATIENTS AND METHODS: Between January 1997 and August 1998 we treated 35 patients with stage cT1-3 N0 M0 prostate cancer. Thirty-two patients with a follow-up of 12 to 28 months (median: 18 months) were evaluated. After ultrasound-guided transrectal implantation of 4 non-parallel needles, CT based 3D brachytherapy treatment planning ("Offenbach system") was performed. All patients received 4 fractions brachytherapy using a fractional dose of 5 or 7 Gy. Time between each fraction was 14 days. After brachytherapy 3D external irradiation followed up to 39.6 or 45.0 Gy. All patients received androgen deprivation, starting 2 to 19 months before brachytherapy, ending 3 months after 3D external radiotherapy. RESULTS: Posttreatment PSA levels dropped to < 1.5 ng/ml in 29/32 patients (91%). In 25 patients PSA levels were < 0.5 ng/ml, in 4 patients 0.5 to 1.5 ng/ml. In 2 patients we noted biochemical relapse. Transrectal implantation was very well tolerated. Grade 3 acute urinary toxicity occurred in 1 patient. We noted no Grade 2 or higher acute gastrointestinal toxicity. One patient developed a Grade 3 late urinary toxicity. No patient showed late gastrointestinal side effects. All 140 dose-volume histograms for 3D HDR brachytherapy were analyzed. CONCLUSIONS: The new 3D HDR brachytherapy technique, combined with 3D external irradiation and androgen deprivation, is a feasible, so far well-tolerated and effective treatment in the short-time follow-up of median 18 months.


Subject(s)
Adenocarcinoma/drug therapy , Adenocarcinoma/radiotherapy , Androgen Antagonists/therapeutic use , Brachytherapy/methods , Photons/therapeutic use , Prostatic Neoplasms/drug therapy , Prostatic Neoplasms/radiotherapy , Adenocarcinoma/blood , Adenocarcinoma/diagnosis , Aged , Biopsy , Brachytherapy/adverse effects , Combined Modality Therapy , Feasibility Studies , Follow-Up Studies , Humans , Male , Middle Aged , Particle Accelerators , Photons/adverse effects , Prostate/pathology , Prostate-Specific Antigen/blood , Prostate-Specific Antigen/radiation effects , Prostatic Neoplasms/blood , Prostatic Neoplasms/diagnosis , Radiotherapy Dosage , Time Factors
11.
Int J Radiat Oncol Biol Phys ; 47(5): 1323-9, 2000 Jul 15.
Article in English | MEDLINE | ID: mdl-10889386

ABSTRACT

PURPOSE: To present the development of a new navigation and reconstruction system based on an electromagnetic free-hand tracker and on CT imaging for treatment planning of intraoperative high-dose-rate brachytherapy (IORT-HDRB) in the sacral region. Our aim is to improve accuracy and to enable individualized treatment planning and dose documentation to be performed for IORT-HDRB using a flab technique. METHODS AND MATERIALS: The material consists of an electromagnetic 3D tracker system, a PC workstation with Microsoft Windows NT 4.0 operating system, and a recognition program for continuous speech. In addition, we designed an external reference system constructed of titanium and Perspex, which is positioned in the pelvis, and a special digitizer pen for reconstruction of the flab geometry. The flab design incorporates a series of silicon 10-mm-diameter spherical pellets. Measurements were made with a pelvic phantom in order to study the accuracy of the system. The reconstruction results are stored and can be exported via network or floppy to our different treatment planning systems. RESULTS: Our results for the reconstruction of a flab with six catheters and a total of 100 spherical pellets give mean errors in the range (2.5 +/- 0.6) mm to (3.5 +/- 0.8) mm depending on the positions of the pelvic phantom and transmitter relative to the operation table. These errors are calculated by comparing the reconstruction results of our system with those using a CT-based reconstruction of the flab geometry. For the accuracy of the navigation system for the pelvic phantom, we obtained mean errors in the range (2.2 +/- 0.7) mm to (3. 1 +/- 1.0) mm. CONCLUSIONS: The new system we have developed enables navigation and reconstruction within the surgical environment with a clinically acceptable level of accuracy. It offers the possibility of individualized treatment planning and effective documentation of the 3D dose distribution in IORT-HDRB using a flab technique.


Subject(s)
Brachytherapy/instrumentation , Colorectal Neoplasms/radiotherapy , Phantoms, Imaging , Radiotherapy Planning, Computer-Assisted/instrumentation , Brachytherapy/methods , Humans , Image Processing, Computer-Assisted , Intraoperative Period , Radiotherapy Planning, Computer-Assisted/methods , Tomography, X-Ray Computed
12.
Radiother Oncol ; 56(1): 49-57, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10869755

ABSTRACT

PURPOSE: To develop a computed tomography (CT) based electromagnetic navigation system for interstitial brachytherapy. This is especially designed for situations when needles have to be positioned adjacent to or within critical anatomical structures. In such instances interactive 3D visualisation of the needle positions is essential. METHODS AND MATERIALS: The material consisted of a Polhemus electromagnetic 3D digitizer, a Pentium 200 MHz laptop and a voice recognition for continuous speech. In addition, we developed an external reference system constructed of Perspex which could be positioned above the tumour region and attached to the patient using a non-invasive fixation method. A specially designed needle holder and patient bed were also developed. Measurements were made on a series of phantoms in order to study the efficacy and accuracy of the navigation system. RESULTS: The mean navigation accuracy of positioning the 20.0 cm length metallic needles within the phantoms was in the range 2.0-4.1 mm with a maximum of 5.4 mm. This is an improvement on the accuracy of a CT-guided technique which was in the range 6.1-11.3 mm with a maximum of 19.4 mm. The mean reconstruction accuracy of the implant geometry was 3.2 mm within a non-ferromagnetic environment. We found that although the needles were metallic this did not have a significant influence. We also found for our experimental setups that the CT table and operation table non-ferromagnetic parts had no significant influence on the navigation accuracy. CONCLUSIONS: This navigation system will be a very useful clinical tool for interstitial brachytherapy applications, particularly when critical structures have to be avoided. It also should provide a significant improvement on our existing technique.


Subject(s)
Brachytherapy , Radiotherapy, Computer-Assisted , Tomography, X-Ray Computed , Electromagnetic Phenomena , Humans , Phantoms, Imaging
16.
Aktuelle Radiol ; 7(5): 270-3, 1997 Sep.
Article in German | MEDLINE | ID: mdl-9410001

ABSTRACT

Preliminary results of a prospective study which investigates the efficacy of preoperative radiotherapy (RT) for prevention of heterotopic ossification (HO) after total hip arthroplasty are summarized. A total number of 20 hip joints (18 patients) were irradiated with a single dose of 6.0 Gy < 4 hours before the surgical procedure. After an average observation period of 6.9 months (range: 6-11 months) the results were evaluated using radiological and clinical criteria. At follow-up, one case (5%) had evidence of high-grade HO (> Brooker grade II). The functional outcome quantified with the Harris score was improved by an average of 37.9 points. The authors conclude that preoperative RT is an effective alternative for postoperative irradiation.


Subject(s)
Arthroplasty, Replacement, Hip , Ossification, Heterotopic/radiotherapy , Postoperative Complications/radiotherapy , Adult , Aged , Aged, 80 and over , Female , Follow-Up Studies , Humans , Male , Middle Aged , Ossification, Heterotopic/diagnostic imaging , Postoperative Complications/diagnostic imaging , Preoperative Care , Prospective Studies , Radiography , Radiotherapy Dosage , Treatment Outcome
17.
Am J Clin Oncol ; 20(4): 407-11, 1997 Aug.
Article in English | MEDLINE | ID: mdl-9256900

ABSTRACT

Therapeutic application of immunoglobulin is reported to be successful in radiation-induced oral and oropharyngeal mucositis. In this study the efficacy of prophylactic application of immunoglobulin was investigated. In 42 patients with head and neck cancer, postoperative radiation treatment or radiation combined with chemotherapy was performed. In 20 consecutive patients, prophylactic mucositis treatment consisted of panthenol (4 x 10 ml/day) and nystatin (4 x 1 ml/day). The 22 following patients received, supplementary to panthenol and nystatin, 800 mg (5 ml) human immunoglobulin intramuscularly once weekly. During the treatment time, the degree of mucositis was examined 3 times a week. The distribution of maximal mucositis degree revealed slightly more severe mucous membrane reaction in the control group compared with the immunoglobulin group (n.s.). The analysis of mean mucositis degrees in both groups demonstrated statistically significant differences (t test, p = 0.031) related to the entire group (n = 42) and to those 16 patients receiving radiation combined with chemotherapy. There was no significant immunoglobulin-induced effect on mucositis in patients treated by radiation alone. The time from the beginning of therapy to the first interruption could be prolonged 5 days in the immunoglobulin group (n.s.). In conclusion, it is demonstrated that the prophylactic application of immunoglobulin seems to lower the degree of radiation-induced mucositis. In comparison to the published data about therapeutically given immunoglobulin, the clinical efficacy of the prophylactic application of immunoglobulin as it is performed in this study is less evident.


Subject(s)
Carcinoma, Squamous Cell/radiotherapy , Head and Neck Neoplasms/radiotherapy , Immunization, Passive , Immunoglobulins/administration & dosage , Radiation Injuries/prevention & control , Stomatitis/prevention & control , Adult , Aged , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/therapeutic use , Carcinoma, Squamous Cell/drug therapy , Combined Modality Therapy , Female , Head and Neck Neoplasms/drug therapy , Humans , Injections, Intramuscular , Laryngeal Neoplasms/radiotherapy , Male , Middle Aged , Mouth Mucosa/radiation effects , Mouth Neoplasms/radiotherapy , Mouthwashes , Nystatin/administration & dosage , Nystatin/therapeutic use , Oropharynx/radiation effects , Pantothenic Acid/administration & dosage , Pantothenic Acid/analogs & derivatives , Pantothenic Acid/therapeutic use , Pharyngeal Neoplasms/radiotherapy , Pharyngitis/prevention & control , Radiotherapy/adverse effects
18.
Aktuelle Radiol ; 7(3): 130-4, 1997 May.
Article in German | MEDLINE | ID: mdl-9296607

ABSTRACT

Magnetic resonance imaging (MRI) was performed in 42 patients with proven microadenomas and in 42 patients with normal pituitary hormone analysis. The normal MRI--anatomy of the pituitary gland and its possible variations with measurement of the volume and comparison of the anatomy with that of the gland after changes caused by microadenomas has to our knowledge not yet described. In this study we measured the height, coronary and sagittal diameter of the pituitary gland in both groups as well as other indirect signs of microadenomas (asymmetry of the gland, sella turcica, and the stalk). The pituitary volume indicates the expansion of microadenomas much better than the gland height (and the other diameters). Normal pituitary glands showed a significant lower volume (525 +/- 137 mm3 [R = 225-800 mm3]) than patients with proven microadenomas (734 +/- 393 mm3 [R = 335-2800 mm3], p < 0.001). The normal pituitary gland and sella turcica show a large variety of anatomic variations. These variations are less frequent in healthy subjects (10-21%) than in patients with microadenomas (48-71%). The described criteria are of some value in diagnosis of a suspected gland hypertrophy or microadenoma. In 75% of the patients with normal pituitary parameters and in 12% of the patients with microadenomas no indirect adenoma criteria was found in our study.


Subject(s)
Adenoma/diagnosis , Pituitary Gland/pathology , Pituitary Neoplasms/diagnosis , Adenoma/pathology , Adenoma/surgery , Adult , Female , Humans , Hypertrophy , Hypophysectomy , Male , Middle Aged , Paraneoplastic Endocrine Syndromes/diagnosis , Paraneoplastic Endocrine Syndromes/pathology , Paraneoplastic Endocrine Syndromes/surgery , Pituitary Neoplasms/pathology , Pituitary Neoplasms/surgery , Reference Values
19.
Dtsch Med Wochenschr ; 122(9): 247-52, 1997 Feb 28.
Article in German | MEDLINE | ID: mdl-9102289

ABSTRACT

OBJECTIVE: To assess the efficacy of radiotherapy in alleviating pain at rest and on exercise in tennis elbow (humeral epicondylitis). PATIENTS AND METHODS: 45 elbow joints in 41 patients were radiated with a telecobalt unit in six sessions at a dose of 1.0 Gy each spread over 3 weeks. Indication for this treatment was pain in the elbow joint at rest, on pressure and on exercise. The patients were re-assessed after a mean follow-up period of 7.5 weeks. They were graded into one of five groups on the basis of their own assessment. Pain on exercise was determined by the Thompson hand-grip, chair test, forced extension and middle-finger stretch test. RESULTS: Satisfactory analgesia was achieved in 31 of 45 elbow joints (68.9%). About 50% of patients still had objectifiable pain on exercise. CONCLUSIONS: Radiotherapy is a highly efficacious means of pain alleviation in tennis elbow, but the results are better for pain at rest than on exercise. The Thompson hand-grip and chair test, positive in more than 90% of patients, proved to be reliable criteria to assess the indications for radiotherapy and its results.


Subject(s)
Tennis Elbow/radiotherapy , Adult , Chronic Disease , Cobalt Radioisotopes/therapeutic use , Female , Humans , Male , Middle Aged , Prospective Studies , Radioisotope Teletherapy , Radiotherapy Dosage , Remission Induction , Tennis Elbow/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL
...